Disc Medicine, Inc.
For the period ended Dec 31, 2025. Filed Feb 26, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 26, 2026
IRON$84.64+4.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations and Comprehensive Loss
| Year EndedDecember 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Operating expenses: | |||
| Research and development | $170,640 | $96,671 | $69,264 |
| Selling, general and administrative | 65,382 | 33,049 | 21,861 |
| Total operating expenses | 236,022 | 129,720 | 91,125 |
| Loss from operations | (236,022) | (129,720) | (91,125) |
| Other income (expense), net: | |||
| Interest income | 27,761 | 21,292 | 14,797 |
| Interest expense | (3,607) | (572) | — |
| Other income (expense) | 45 | (2) | (2) |
| Total other income (expense), net | 24,199 | 20,718 | 14,795 |
| Loss before income taxes | (211,823) | (109,002) | (76,330) |
| Income tax expense | (361) | (355) | (99) |
| Net loss | $(212,184) | $(109,357) | $(76,429) |
| Net loss per share, basic and diluted | $(6.01) | $(3.96) | $(3.42) |
| Weighted-average common shares outstanding, basic and diluted | 35,295,663 | 27,606,022 | 22,315,877 |
| Comprehensive loss: | |||
| Net loss | $(212,184) | $(109,357) | $(76,429) |
| Other comprehensive income: | |||
| Foreign currency translation adjustments | (1) | (27) | — |
| Unrealized gain on marketable securities | 677 | 316 | — |
| Total other comprehensive income | 676 | 289 | — |
| Comprehensive loss | $(211,508) | $(109,068) | $(76,429) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.